$Inhibikas_老虎社区_美港股上老虎

wow, about 6 times difference💵💵💵

JonesTrading Initiates Coverage On Inhibikase Therapeutics with Buy Rating, Announces Price Target of $12

Jones Trading以买入评级启动Inhibikase治疗药物的覆盖范围，宣布目标价为12美元

点击播放语音资讯

约 1 分钟

07/15/2021 09:32 ET Benzinga Real-time News

JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.

Jones Trading分析师Soumit Roy以买入评级启动Inhibikase治疗公司(纳斯达克市场代码：IKT)的报道，并宣布目标价为12美元。

$ContextLogic Inc.(WISH)$

$Sundial Growers Inc.(SNDL)$

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":147204788,"tweetId":"147204788","gmtCreate":1626358206644,"gmtModify":1631884501152,"author":{"id":3556171902294012,"authorId":3556171902294012,"authorIdStr":"3556171902294012","name":"海洋洲huathuat","avatar":"https://static.tigerbbs.com/8a14555a794f7679714ce8fa9716f7e1","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":48,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><a href=\"https://laohu8.com/S/IKT\">$Inhibikase Therapeutics, Inc.(IKT)$</a>wow, about 6 times difference💵💵💵JonesTrading Initiates Coverage On Inhibikase Therapeutics with Buy Rating, Announces Price Target of $12Jones Trading以买入评级启动Inhibikase治疗药物的覆盖范围，宣布目标价为12美元点击播放语音资讯约 1 分钟07/15/2021 09:32 ET Benzinga Real-time News&nbsp;JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12. Jones Trading分析师Soumit Roy以买入评级启动Inhibikase治疗公司(纳斯达克市场代码：IKT)的报道，并宣布目标价为12美元。 <a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a><a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/IKT\">$Inhibikase Therapeutics, Inc.(IKT)$</a>wow, about 6 times difference💵💵💵JonesTrading Initiates Coverage On Inhibikase Therapeutics with Buy Rating, Announces Price Target of $12Jones Trading以买入评级启动Inhibikase治疗药物的覆盖范围，宣布目标价为12美元点击播放语音资讯约 1 分钟07/15/2021 09:32 ET Benzinga Real-time News&nbsp;JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12. Jones Trading分析师Soumit Roy以买入评级启动Inhibikase治疗公司(纳斯达克市场代码：IKT)的报道，并宣布目标价为12美元。 <a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a><a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a></body></html>","text":"$Inhibikase Therapeutics, Inc.(IKT)$ wow, about 6 times difference💵💵💵 JonesTrading Initiates Coverage On Inhibikase Therapeutics with Buy Rating, Announces Price Target of $12 Jones Trading以买入评级启动Inhibikase治疗药物的覆盖范围，宣布目标价为12美元 点击播放语音资讯 约 1 分钟 07/15/2021 09:32 ET Benzinga Real-time News JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12. Jones Trading分析师Soumit Roy以买入评级启动Inhibikase治疗公司(纳斯达克市场代码：IKT)的报道，并宣布目标价为12美元。 $ContextLogic Inc.(WISH)$ $Sundial Growers Inc.(SNDL)$","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/147204788","repostId":0,"isVote":1,"tweetType":1,"viewCount":2479,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["IKT","SNDL","WISH"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":574,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/147204788"}